Pyriformis muscle syndrome: CT/MR findings in the percutaneous therapy with botulinic toxin;Sindrome del musculo piriforme: Diagnostica integrata TC/RM nella terapia percutanea con tossina botulinica

Radiologia Medica

Volumn 105, Issue 1-2, 2003, Pages 69-75

  Fanucci, Ezio ^a,b,c   Masala, Salvatore ^a   Squillaci, Ettore ^a   Sodani, Giulio ^a   Varrucciu, Viviana ^a   Ursone, Antonio ^a   Simonetti, Giovanni ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^c Università Campus Bio Medico di Roma   (Italy)

Author keywords

Botulinum toxin; Pyriformis; Pyriformis syndrome; Therapy

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ELECTROPHYSIOLOGY; FEMALE; HUMAN; MALE; MUSCLE ATROPHY; MUSCLE CONTRACTION; MUSCLE DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PYRIFORMIS MUSCLE SYNDROME; RISK FACTOR; SIGNAL NOISE RATIO; SITTING; TECHNIQUE;

ADULT; BOTULINUM TOXIN TYPE A; BUTTOCKS; DRUG THERAPY, COMPUTER-ASSISTED; ELECTROMYOGRAPHY; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE COMPRESSION SYNDROMES; SCIATICA; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0038369877     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Armstrong MW: Treatment of facial synkinesis and facial asymmetry with botulinum toxin type A following facial nerve palsy. Clin Otolaryngol 21: 15-20, 1996.
2. Beatty RA: The pyriformis muscle syndrome: a simple diagnostic manoeuvre. Neurosurgery 34: 512-551, 1994.
3. Bhakta BB: Treatment of chronic lumb spasticity with botulinum toxin. A J Neurol Neurosurg Psychiatry 59: 562, 1995.
4. Brown JA, Braun MA, Namey TC: Pyriformis syndrome in a 10-year-old boy as a complication of operation with the patient in the sitting position. Neurosurgery 23: 117-119, 1998.
5. Cheshire WP, Abashian SW, Dougls Mann J: Botulinum toxin in the treatment of myofascial pain syndrome. Pain 59: 65-69, 1994.
6. Eibel P: Pyriformis syndrome. Lancet 2: 1220, 1987.
7. Fishman SM, Caneris OA, Bandman TB et al: Injection of the pyriformis muscle by fluoroscopic and electromyographic guidance. Reg Anesth Pain Med 23: 554-559, 1998.
8. Hallin R: Sciatic pain and the pyriformis muscle. Postgrad Med 74: 69, 1983.
9. Hanania M, Kitain E: Perisciatic injection of steroid for the treatment of sciatica due to pyriformis syndrome. Reg Anesth Pain Med 23: 223-228, 1998.
10. Hong CZ, Hsueh TC: Difference in pain relief after trigger point injections in myofascial pain patients with and without fibromyalgia. Arch Phys Med Rehabil 77: 1161-1166, 1996.
11. Jancovic J, Brin MF: Therapeutic uses of botulinum toxin. N Engl J Med 324: 1186-1194, 1991.
12. Jankiewicz JJ, Hennrikus WL, Houkom JA: The appearance of the pyriformis muscle syndrome in computed tomography and magnetic resonance imaging. Clin Orthopedics and Rel Res 262: 205-209, 1991.
13. Mizuguchi T: Division of the pyriformis muscle for the treatment of sciatica. Postlaminectomy syndrome and osteoarthritis of the spine. Arch Surg 111: 719-722, 1976.
14. Pace JB, Nagle D: Pyriformis syndrome. West J Med 124: 435-439, 1976.
15. Parziale JR, Hudgins TH, Fishman LM: The pyriformis syndrome. Am J Orthop 25: 819-823, 1996.
16. Pecina M: Contribution to the etiological explanation of the pyriformis syndrome. Acta Anat 105: 181-187, 1979.
17. Porta M: A comparative trial of botulinum toxin A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain 85: 101-105, 2000.
18. Simpson LL: The origin, structure and pharmacologic activity of botulinum toxin. Pharmacol Rev 33: 155-188, 1991.
19. Synek VM: The pyriformis syndrome: review and case presentation. Clin Exp Neurol 23: 31-37, 1987.
20. Rodrigue T, Hardy RW: Diagnosis and treatment of pyriformis syndrome. Neur Clin of N A 12: 311-319, 2001.